Atlas Trials

To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement

Clinical trial NCT05116215 · UNKNOWN

Trial details

NCT number
NCT05116215
Sponsor
HoHo Biotech
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Autoimmune Diseases
Start date
2021-08-13
Primary completion
2022-08-12
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.